Your browser doesn't support javascript.
loading
Prognostic value of coronary computed tomography angiography compared to radionuclide myocardial perfusion imaging in patients With coronary stents.
Abazid, Rami M; Romsa, Jonathan G; Warrington, James C; Akincioglu, Cigdem; Smettei, Osama A; Bureau, Yves; Tzemos, Nikolaos; Vezina, William C.
Afiliación
  • Abazid RM; Division of Nuclear Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.
  • Romsa JG; Division of Nuclear Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.
  • Warrington JC; Division of Nuclear Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.
  • Akincioglu C; Division of Nuclear Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.
  • Smettei OA; Division of Nuclear Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.
  • Bureau Y; Medical Biophysics, Western University, London, ON, Canada.
  • Tzemos N; Department of Psycholoy, Lawson Health Research Institute, London, ON, Canada.
  • Vezina WC; Division of Cardiology, Department of Internal Medicine, London Health Sciences Centre, University Hospital, London, ON, Canada.
Front Cardiovasc Med ; 10: 1087113, 2023.
Article en En | MEDLINE | ID: mdl-37008323
ABSTRACT

Objectives:

The aim of this study is to compare the prognostic value of coronary computed tomography angiography (CCTA) with single-photon emission computed tomography (SPECT) in predicting cardiovascular events in patients with stents.

Design:

Retrospective analysis.

Setting:

University Hospital, London, Ontario Canada.

Participants:

Between January 2007 and December 2018, 119 patients post-percutaneous coronary intervention (PCI) who were referred for hybrid imaging with CTA and 2-day rest/stress SPECT were enrolled. Primary and secondary outcome

measures:

Patients were followed for any major adverse cardiovascular event (MACE) including All-cause mortality, Non-fatal myocardial infarction (MI), Unplanned revascularization, Cerebrovascular accident and hospitalization for arrhythmia or heart failure. We define hard cardiac events (HCE) as cardiac death, non-fatal MI or unplanned revascularization. We used two cut-off values to define obstructive lesions with CCTA ≥50% and ≥70% in any coronary segment. SPECT scan defined as abnormal in the presence of >5% reversible myocardial perfusion defect.

Results:

During the follow-up period of 7.2 ± 3.4 years. 45/119 (37.8%) patients experienced 57 MACE Ten deaths (2 cardiac deaths and 8 of non-cardiac deaths), 29 acute coronary syndrome including non-fatal MI (25 required revascularization), 7 hospitalizations for heart failure, 6 cerebrovascular accidents and 5 new atrial fibrillation. 31 HCEs were reported. Cox regression analysis showed that obstructive coronary stenosis (≥50% and ≥70%) and abnormal SPECT were associated of MACE (p = 0.037, 0.018 and 0.026), respectively. In contrast, HCEs were significantly associated with obstructive coronary stenosis of ≥50% and ≥70% with p = 0.004 and p = 0.007, respectively. In contrast, abnormal SPECT was a nonsignificant predictor of HCEs (p = 0.062).

Conclusion:

Obstructive coronary artery stenosis on CCTA can predict MACE and HCE. However, abnormal SPECT can only predict MACE but not HCE in patients post-PCI with a follow-up period of approximately 7 years.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá